“…We and others have also suggested the use of erythropoietin in the treatment of severe pneumolysis cases (Ehrenreich et al, 2020;Soliz et al, 2020; as it can help improve the oxygen transport to tissues of the compromised oxygen transport triad (pneumo-dynamic pump, hemo-dynamic pump, and hemoglobin) described before . Several other authors are also suggesting the use of erythropoietin due not only to the increase of red blood cells, hematocrit and hemoglobin but also to the neuroprotective effects of the hormone itself in different tissues like the heart, the vessels, and the brain (Brenner, 2021;Ehrenreich et al, 2020;Fishbane and Hirsch, 2020;Hadadi et al, 2020;Leventhal et al, 2020;Sahebnasagh et al, 2020).Furthermore, the increase of hemoglobin becomes a fundamental factor of hypoxia tolerance as previously described in the Formula of Tolerance to hypoxia = Hb/PaCO2 * 3.01. This formula states that higher hemoglobin and a lower PaCO2 give greater tolerance to hypoxia (Zubieta-Calleja, G.R., Ardaya, G., Zubieta, N., Paulev, 2013).…”